Several studies have demonstrated the tumor-suppressor activities of ZHX2 in hepatocellular carcinoma (HCC) and other malignancies (Table 2), but accumulating evidence has also shown that ZHX2 plays oncogenic roles in carcinogenesis and progression in various cancers (Table 2). This evidence concerns the gene ZHX2 and cancer.